BILL ANALYSIS
|
Senate Research Center |
S.B. 1138 |
|
88R10498 KBB-F |
By: Schwertner |
|
|
Health & Human Services |
|
|
4/17/2023 |
|
|
As Filed |
AUTHOR'S / SPONSOR'S STATEMENT OF INTENT
White bagging is a pharmacy practice where an insurer requires a drug to be purchased through their specialty pharmacy and shipped directly to a provider's office for a specific patient. This is particularly problematic in cancer care where patients require chemotherapy drugs to be administered by a provider, and their needs are highly personalized or may change daily. By removing the provider, with whom the patient has a relationship, from the process, patients are unable to receive care in a way they choose. Additionally, the practice of white bagging can delay treatment, create drug waste, compromise the integrity of a drug, and increase out-of-pocket costs.
S.B. 1138 will amplify patient choice in dispensing and administration of certain specialty drugs by prohibiting health plans from requiring that clinician-administered drugs be dispensed by their affiliated pharmacy and limiting pharmacy benefits for such prescriptions.
As proposed, S.B. 1138 amends current law relating to health benefit plan coverage of clinician-administered drugs.
RULEMAKING AUTHORITY
This bill does not expressly grant any additional rulemaking authority to a state officer, institution, or agency.
SECTION BY SECTION ANALYSIS
SECTION 1. Amends Chapter 1369, Insurance Code, by adding Subchapter Q, as follows:
SUBCHAPTER Q. CLINICIAN-ADMINISTERED DRUGS
Sec. 1369.761. DEFINITIONS. Defines "administer," "clinician-administered drug," "health care provider," and "physician."
Sec. 1369.762. APPLICABILITY OF SUBCHAPTER. (a) Provides that this subchapter applies only to a health benefit plan that provides benefits for medical or surgical expenses incurred as a result of a health condition, accident, or sickness, including an individual, group, blanket, or franchise insurance policy or insurance agreement, a group hospital service contract, or an individual or group evidence of coverage or similar coverage document that is offered by:
(1) an insurance company;
(2) a group hospital service corporation operating under Chapter 842 (Group Hospital Service Corporations);
(3) a health maintenance organization operating under Chapter 843 (Health Maintenance Organization);
(4) an approved nonprofit health corporation that holds a certificate of authority under Chapter 844 (Certification of Certain Nonprofit Health Corporations);
(5) a multiple employer welfare arrangement that holds a certificate of authority under Chapter 846 (Multiple Employer Welfare Arrangements);
(6) a stipulated premium company operating under Chapter 884 (Stipulated Premium Insurance Companies);
(7) a fraternal benefit society operating under Chapter 885 (Fraternal Benefit Societies);
(8) a Lloyd's plan operating under Chapter 941 (Lloyd's Plan); or
(9) an exchange operating under Chapter 942 (Reciprocal and Interinsurance Exchanges).
(b) Provides that this subchapter, notwithstanding any other law, applies to:
(1) a small employer health benefit plan subject to Chapter 1501 (Health Insurance Portability and Availability Act), including coverage provided through a health group cooperative under Subchapter B (Coalitions and Cooperatives) of that chapter;
(2) a standard health benefit plan issued under Chapter 1507 (Consumer Choice of Benefits Plans);
(3) health benefits provided by or through a church benefits board under Subchapter I (Church Benefits Boards), Chapter 22, Business Organizations Code;
(4) group health coverage made available by a school district in accordance with Section 22.004 (Group Health Benefits for School Employees), Education Code;
(5) a regional or local health care program operating under Section 75.104 (Health Care Services), Health and Safety Code; and
(6) a self-funded health benefit plan sponsored by a professional employer organization under Chapter 91 (Professional Employer Organizations), Labor Code.
Sec. 1369.763. EXCEPTIONS TO APPLICABILITY OF SUBCHAPTER. Provides that this subchapter does not apply to an issuer or provider of health benefits under or a pharmacy benefit manager administering pharmacy benefits under:
(1) the state Medicaid program, including the Medicaid managed care program under Chapter 533 (Medicaid Managed Care Program), Government Code;
(2) the child health plan program under Chapter 62 (Child Health Plan for Certain Low-Income Children), Health and Safety Code;
(3) the TRICARE military health system; or
(4) a workers' compensation insurance policy or other form of providing medical benefits under Title 5 (Workers' Compensation), Labor Code.
Sec. 1369.764. CERTAIN LIMITATIONS ON COVERAGE OF CLINICIAN-ADMINISTERED DRUGS PROHIBITED. (a) Prohibits a health benefit plan issuer from, for an enrollee with a chronic, complex, rare, or life-threatening medical condition:
(1) requiring clinician-administered drugs to be dispensed only by certain pharmacies or only by pharmacies participating in the health benefit plan issuer's network;
(2) if a clinician-administered drug is otherwise covered, limiting or excluding coverage for such drugs based on the enrollee's choice of pharmacy, or because the drug was not dispensed by a pharmacy that participates in the health benefit plan issuer's network;
(3) reimbursing at a lesser amount clinician-administered drugs based on the enrollee's choice of pharmacy, or because the drug was dispensed by a pharmacy that does not participate in the health benefit plan issuer's network; or
(4) requiring that an enrollee pay an additional fee, higher copay, higher coinsurance, second copay, second coinsurance, or any other price increase for clinician-administered drugs based on the enrollee's choice of pharmacy, or because the drug was not dispensed by a pharmacy that participates in the health benefit plan issuer's network.
(b) Provides that nothing in in this section is authorized to be construed to:
(1) authorize a person to administer a drug when otherwise prohibited under the laws of this state or federal law; or
(2) modify drug administration requirements under the laws of this state, including any requirements related to delegation and supervision of drug administration.
SECTION 2. Makes application of Subchapter Q, Chapter 1369, Insurance Code, as added by this Act, prospective to January 1, 2024.
SECTION 3. Effective date: September 1, 2023.